NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Mar 5, 2024 (Letter of inquiry)

Later predicted deadlines: Apr 5, 2024 (Full proposal)

Grant amount: Up to US $5,500,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

(Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.